| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.56 | 0.05 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.38 | 0.2 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.15 | 0.0008 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.15 | 0.3 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |